RAYMOND JAMES FINANCIAL INC·4

Feb 23, 3:54 PM ET

MCGEARY RODERICK C 4

Research Summary

AI-generated summary

Updated

Raymond James (RJF) Director Roderick C. McGeary Receives Award

What Happened

  • Roderick C. McGeary, a director of Raymond James Financial Inc. (RJF), received a grant of 1,303 Deferred Restricted Stock Units (DRSUs) on February 19, 2026. The grant shows an acquisition price of $0.00 (this is a compensation award, not a cash purchase).
  • DRSUs convert one-for-one into common shares upon vesting and include accrued cash in lieu of dividends. This Form 4 reports the routine annual director grant and does not reflect an open-market purchase or sale.

Key Details

  • Transaction date and price: 2026-02-19 — 1,303 DRSUs @ $0.00 (code A — award/grant).
  • Ownership after transaction: not specified on the provided Form 4; the grant itself consists of 1,303 DRSUs (see footnote).
  • Footnotes: F1 — DRSUs convert to shares at vest and include cash in lieu of dividends; they vest at the next annual shareholders meeting (or by March 15 of the following year). McGeary irrevocably elected to defer settlement until the third anniversary of the vest date. F2 — the reported amount includes DRSUs.
  • Filing timeliness: Form filed on Feb 23, 2026 for a Feb 19, 2026 grant — reported within the normal 2-business-day window.

Context

  • This is a standard director compensation award (annual grant) rather than a market purchase or sale. Such grants are routine and intended as long-term compensation; they do not by themselves indicate an insider buying or selling shares for market sentiment.